PaxMedica, Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported net loss was USD 16.46 million compared to USD 3.45 million a year ago. Basic loss per share from continuing operations was USD 2.5 compared to USD 0.85 a year ago.
Market Closed -
Other stock markets
|
After market 04:25:23 pm | |||
0.692 USD | -3.35% | 0.711 | +2.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.59% | 5.35M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- PXMD Stock
- News PaxMedica, Inc.
- PaxMedica, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021